NCT02091999 2024-11-01A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4Astellas Pharma IncPhase 1 Completed213 enrolled